KPC-3 carbapenemase inhibition with DBO-urea or carbamate series compounds would collapse co-selected resistance across 9 drug classes due to network hub centrality
Adversarial Debate Score
36% survival rate under critique
Model Critiques
Supporting Research Papers
- Characterization of the novel transposon Tn7722 harboring bla NDM-1 : Insights into the evolutionary dynamics of resistance in Klebsiella pneumoniae
Background: Klebsiella pneumoniae is a major opportunistic pathogen responsible for various invasive infections. The rise of carbapenem-resistant K. pneumoniae, primarily due to acquisition of bla NDM...
- The evolutionary trade-offs in phage-resistant Klebsiella pneumoniae entail cross-phage sensitization and loss of multidrug resistance.
Bacteriophage therapy is currently being evaluated as a critical complement to traditional antibiotic treatment. However, the emergence of phage resistance is perceived as a major hurdle to the sustai...
- Identification of Evolutionary Trade‐Offs Associated With High‐Level Colistin Resistance in Acinetobacter baumannii
Colistin (COL) belongs to the polymyxin group of drugs, which possesses a positive charge and interacts with lipopolysaccharide (LPS) of Gram‐negative bacterial outer membranes. Acinetobacter baumanni...
- Identification of Evolutionary Trade-Offs Associated with High-Level Colistin Resistance in Acinetobacter baumannii
Colistin (COL) belongs to the polymyxin group of drugs which possesses a positive charge and interacts with lipopolysaccharide (LPS) of Gram-negative bacterial outer membrane. Additionally, it can pen...
Formal Verification
Z3 checks whether the hypothesis is internally consistent, not whether it is empirically true.